0001079973-17-000176.txt : 20170322 0001079973-17-000176.hdr.sgml : 20170322 20170322161324 ACCESSION NUMBER: 0001079973-17-000176 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170322 DATE AS OF CHANGE: 20170322 EFFECTIVENESS DATE: 20170322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioptix, Inc. CENTRAL INDEX KEY: 0001167419 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 841553387 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-283110 FILM NUMBER: 17706801 BUSINESS ADDRESS: STREET 1: 1775 38TH STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-545-5550 MAIL ADDRESS: STREET 1: 1775 38TH STREET CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Venaxis, Inc. DATE OF NAME CHANGE: 20121218 FORMER COMPANY: FORMER CONFORMED NAME: AspenBio Pharma, Inc. DATE OF NAME CHANGE: 20051110 FORMER COMPANY: FORMER CONFORMED NAME: ASPENBIO INC DATE OF NAME CHANGE: 20020213 D 1 primary_doc.xml X0707 D LIVE 0001167419 Bioptix, Inc. 1775 38TH STREET BOULDER CO COLORADO 80301 303-545-5550 COLORADO Venaxis, Inc. AspenBio Pharma, Inc. ASPENBIO INC Corporation true Stephen T. Lundy c/o Bioptix, Inc. 1775 38th Street Boulder CO COLORADO 80301 Executive Officer Director Chief Executive Officer, President Jeffrey G. McGonegal c/o Bioptix, Inc. 1775 38th Street Boulder CO COLORADO 80301 Executive Officer Chief Financial Officer John R. O'Rourke c/o Bioptix, Inc. 1775 38th Street Boulder CO COLORADO 80301 Director Michael M. Beeghley c/o Bioptix, Inc. 1775 38th Street Boulder CO COLORADO 80301 Director Mike T. Dai c/o Bioptix, Inc. 1775 38th Street Boulder CO COLORADO 80301 Director Biotechnology Decline to Disclose 06b false 2017-03-16 false true true true true Promissory Notes, Warrants convertible and exercisable into common stock false 0 4750000 4750000 0 false 10 0 200000 Financial Advisory Fee to Canaccord Genuity Inc. 0 false Bioptix, Inc. /s/ Jeffrey McGonegal Jeffrey McGonegal Chief Financial Officer 2017-03-22